share_log

BTIG Maintains Buy on Acutus Medical, Lowers Price Target to $1.5

Benzinga Real-time News ·  Jun 24, 2022 09:20

BTIG analyst Marie Thibault maintains Acutus Medical (NASDAQ:AFIB) with a Buy and lowers the price target from $2 to $1.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment